Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061

Gianmatteo Vit, Joana Duro, Girish Rajendraprasad, Emil P.T. Hertz, Lya Katrine Kauffeldt Holland, Melanie Bianca Weisser, Brennan C. McEwan, Blanca Lopez-Mendez, Paula Sotelo-Parrilla, A. Arockia Jeyaprakash, Guillermo Montoya, Niels Mailand, Kenji Maeda, Arminja Kettenbach, Marin Barisic, Jakob Nilsson*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Abstract

Protein phosphatase 2A (PP2A) is an abundant phosphoprotein phosphatase that acts as a tumor suppressor. For this reason, compounds able to activate PP2A are attractive anticancer agents. The compounds iHAP1 and DT-061 have recently been reported to selectively stabilize specific PP2A-B56 complexes to mediate cell killing. We were unable to detect direct effects of iHAP1 and DT-061 on PP2A-B56 activity in biochemical assays and composition of holoenzymes. Therefore, we undertook genome-wide CRISPR-Cas9 synthetic lethality screens to uncover biological pathways affected by these compounds. We found that knockout of mitotic regulators is synthetic lethal with iHAP1 while knockout of endoplasmic reticulum (ER) and Golgi components is synthetic lethal with DT-061. Indeed we showed that iHAP1 directly blocks microtubule assembly both in vitro and in vivo and thus acts as a microtubule poison. In contrast, DT-061 disrupts both the Golgi apparatus and the ER and lipid synthesis associated with these structures. Our work provides insight into the biological pathways perturbed by iHAP1 and DT-061 causing cellular toxicity and argues that these compounds cannot be used for dissecting PP2A-B56 biology.

Original languageEnglish
Article numbere110611
Number of pages21
JournalEMBO Journal
Early online date13 Jun 2022
DOIs
Publication statusE-pub ahead of print - 13 Jun 2022

Keywords

  • chemogenic profiling
  • DT-061
  • iHAP1
  • phosphatase
  • PP2A

Fingerprint

Dive into the research topics of 'Chemogenetic profiling reveals PP2A-independent cytotoxicity of proposed PP2A activators iHAP1 and DT-061'. Together they form a unique fingerprint.

Cite this